Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02749474 · ClinicalTrials.gov registry record
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
A clinical trial of Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related, sponsored by The Cooper Health System.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT02749474 is a study of Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related that is actively recruiting participants, run by The Cooper Health System. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02749474, a study of Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related, is actively recruiting participants, sponsored by The Cooper Health System.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to follow the treatment options offered to pregnant women diagnosed with cancer and study the impact that their treatment or delay of treatment has on their own health and that of their children.
Conditions Studied
Study Locations (1)
New Jersey
- Cooper University Hospital - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2003-07 |
| Est. Completion | 2025-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02749474
The ClinicalTrials.gov registry entry for NCT02749474 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related appearing as the primary indexed condition, and to 0 interventions.
NCT02749474 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT02749474 about?
NCT02749474 is a clinical study titled "Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes". The objective of this study is to follow the treatment options offered to pregnant women diagnosed with cancer and study the impact that their treatment or delay of treatment has on their own health and that of their children.
What is the current status of trial NCT02749474?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2003-07. Estimated completion is 2025-07.
What conditions does trial NCT02749474 study?
This clinical trial studies the following conditions: Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related.
Who is sponsoring clinical trial NCT02749474?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02749474 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.